Novavax COVID-19 vaccine: How it works and other things you should know

How the United States' potential fourth vaccine stacks up against existing ones:

While the vaccine still needs to be greenlighted by U.S. regulators, Novavax is on track to manufacture 100 million doses per month by the end of the third quarter and 150 million doses per month by the end of the fourth quarter. The company said it intends to apply for emergency use authorization from the Food & Drug Administration by this fall and plans to share more details from its Phase 3 trials as that data becomes available.

Pfizer and Moderna use mRNA technology that teaches cells to make a protein that prompts an immune response. The Johnson & Johnson vaccine uses a

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ABC /  🏆 471. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novavax Says COVID Vaccine Works Against VariantsNovavax’s COVID-19 vaccine is highly effective -- 90.4% effective overall -- and protects against coronavirus variants, the company announced Monday.
Read more »

Novavax COVID-19 vaccine more than 90% effective in U.S. trialNovavax Inc (NVAX.O) on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.
Read more »

Novavax Covid vaccine highly effective in U.S. trials, including against variants, company saysNovavax said it plans to apply to the Food and Drug Administration for emergency use authorization in the third quarter.
Read more »

Novavax announces its COVID-19 vaccine is over 90% effective against symptomatic diseaseJUST IN: American biotechnology company Novavax announces that its experimental COVID-19 vaccine is more than 90% effective against symptomatic disease in late-stage clinical trials.
Read more »

Large study finds that vaccine maker Novavax's shot is about 90% effectiveVaccine maker Novavax said its shot was highly effective against COVID-19 and also protected against variants in a large, late-stage study in the U.S. and Mexico.
Read more »